NYSE:CVS - CVS Health Stock Price, News & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Wednesday, July 10th. Stockholders of record on Thursday, July 25th will be paid a dividend of $0.50 per share on Friday, August 2nd. This represents a $2.00 annualized dividend and a dividend yield of 3.15%. The ex-dividend date is Wednesday, July 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) issued its earnings results on Wednesday, August, 7th. The pharmacy operator reported $1.89 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.70 by $0.19. The pharmacy operator earned $63.43 billion during the quarter, compared to analyst estimates of $62.66 billion. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. The firm's revenue was up 35.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.69 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY19 earnings guidance on Wednesday, August, 7th. The company provided EPS guidance of $6.89-7.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.84.

27 Wall Street analysts have issued 12-month target prices for CVS Health's shares. Their forecasts range from $61.00 to $100.00. On average, they anticipate CVS Health's stock price to reach $75.9130 in the next year. This suggests a possible upside of 19.6% from the stock's current price. View Analyst Price Targets for CVS Health.

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 1 sell rating, 7 hold ratings, 18 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Media headlines about CVS stock have been trending negative this week, InfoTrie reports. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CVS Health earned a news sentiment score of -2.9 on InfoTrie's scale. They also assigned media stories about the pharmacy operator a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), Cisco Systems (CSCO), NVIDIA (NVDA), Alibaba Group (BABA), Verizon Communications (VZ), Intel (INTC), Home Depot (HD) and Bank of America (BAC).

CVS Health's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (7.87%), Price T Rowe Associates Inc. MD (1.43%), Northern Trust Corp (1.41%), Barrow Hanley Mewhinney & Strauss LLC (1.31%), Morgan Stanley (1.06%) and Bank of New York Mellon Corp (1.05%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Parnassus Investments CA, CIBC Private Wealth Group LLC, Boston Partners, Prudential Financial Inc., UBS Asset Management Americas Inc., Bank of New York Mellon Corp and Pictet Asset Management Ltd.. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, James David Clark, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was bought by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Morgan Stanley, Prudential PLC, Vanguard Group Inc., Parametric Portfolio Associates LLC, Poplar Forest Capital LLC, Invesco Ltd. and LSV Asset Management. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $63.48.

CVS Health has a market capitalization of $82.56 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]